¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"y"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Y71
    Cardiovascular devices associated with adverse incidents
    À¯ÇØ»ç°Ç°ú °ü·ÃµÈ ½ÉÀåÇ÷°ü ÀåÄ¡
  • Y40.1
    Cefalosporins and other ¥â-lactam antibiotics
    ¼¼ÆÈ·Î½ºÆ÷¸° ¹× ±âŸ º£Å¸¶ôŽ Ç×»ýÁ¦
  • Y50.9
    Central nervous system stimulant, unspecified
    »ó¼¼ºÒ¸íÀÇ ÁßÃ߽Űæ°èÅë ÈïºÐÁ¦
  • Y50
    Central nervous system stimulants, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁßÃ߽Űæ°èÅë ÈïºÐÁ¦
  • Y51.8
    Centrally acting and adrenergic-neuron-blocking agents, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁßÃß¼º ÀÛ¿ë ¹× ¾Æµå·¹³ÊÁ÷ ´º·Ð Â÷´ÜÁ¦
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á